Groeneveld GJ - Search Results

1

A randomized sequential trial of creatine in amyotrophic lateral sclerosis.

Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JH, Franssen H, van den Berg LH. Groeneveld GJ, et al. Ann Neurol. 2003 Apr;53(4):437-45. doi: 10.1002/ana.10554. Ann Neurol. 2003. PMID: 12666111 Clinical Trial.

2

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.

Groeneveld GJ, van Kan HJ, Toraño JS, Veldink JH, Guchelaar HJ, Wokke JH, van den Berg LH. Groeneveld GJ, et al. J Neurol Sci. 2001 Oct 15;191(1-2):121-5. doi: 10.1016/s0022-510x(01)00613-x. J Neurol Sci. 2001. PMID: 11677002 Clinical Trial.

3

Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms.

Groeneveld GJ, Van Kan HJ, Kalmijn S, Veldink JH, Guchelaar HJ, Wokke JH, Van den Berg LH. Groeneveld GJ, et al. Neurology. 2003 Oct 28;61(8):1141-3. doi: 10.1212/01.wnl.0000090459.76784.49. Neurology. 2003. PMID: 14581684 Clinical Trial.

4

Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis.

Groeneveld GJ, de Leeuw van Weenen J, van Muiswinkel FL, Veldman H, Veldink JH, Wokke JH, Bär PR, van den Berg LH. Groeneveld GJ, et al. Neurosci Lett. 2003 Dec 11;352(3):175-8. doi: 10.1016/j.neulet.2003.08.062. Neurosci Lett. 2003. PMID: 14625013

5

Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS.

Groeneveld GJ, Van Muiswinkel FL, Sturkenboom JM, Wokke JH, Bär PR, Van den Berg LH. Groeneveld GJ, et al. Brain Res. 2004 Sep 17;1021(1):128-31. doi: 10.1016/j.brainres.2004.06.024. Brain Res. 2004. PMID: 15328040

6

A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis.

van Kan HJ, Spieksma M, Groeneveld GJ, Toraño JS, van den Berg LH, Guchelaar HJ. van Kan HJ, et al. Among authors: groeneveld gj. Biomed Chromatogr. 2004 Nov;18(9):723-6. doi: 10.1002/bmc.384. Biomed Chromatogr. 2004. PMID: 15386583

7

Physical activity and the association with sporadic ALS.

Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH. Veldink JH, et al. Among authors: groeneveld gj. Neurology. 2005 Jan 25;64(2):241-5. doi: 10.1212/01.WNL.0000149513.82332.5C. Neurology. 2005. PMID: 15668420 Review.

8

Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

van Kan HJ, Groeneveld GJ, Kalmijn S, Spieksma M, van den Berg LH, Guchelaar HJ. van Kan HJ, et al. Among authors: groeneveld gj. Br J Clin Pharmacol. 2005 Mar;59(3):310-3. doi: 10.1111/j.1365-2125.2004.02233.x. Br J Clin Pharmacol. 2005. PMID: 15752377 Free PMC article.

9

Few adverse effects of long-term creatine supplementation in a placebo-controlled trial.

Groeneveld GJ, Beijer C, Veldink JH, Kalmijn S, Wokke JH, van den Berg LH. Groeneveld GJ, et al. Int J Sports Med. 2005 May;26(4):307-13. doi: 10.1055/s-2004-817917. Int J Sports Med. 2005. PMID: 15795816 Clinical Trial.

10

Sequential designs for clinical trials in amyotrophic lateral sclerosis.

Groeneveld GJ, van der Tweel I, Wokke JH, van den Berg LH. Groeneveld GJ, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):202-7. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15799547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters